PRESS RELEASE published on 01/13/2025 at 18:00, 1 year 3 months ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converted 4 convertible bonds in Oxurion, leading to a EUR 100,000 capital increase. Oxurion focuses on developing vision-preserving therapeutics for the elderly Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Elderly Vision
PRESS RELEASE published on 01/13/2025 at 18:00, 1 year 3 months ago Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer) volgend op Atlas Conversie-Notificatie Atlas Special Opportunities, LLC convertit 4 obligations convertibles en Oxurion pour une augmentation de capital de 100 000 EUR, soutenant le développement de médicaments pour préserver la vision des personnes âgées Obligations Convertibles Augmentation De Capital Atlas Special Opportunities Médicaments Innovants Oxurion
BRIEF published on 01/06/2025 at 18:05, 1 year 4 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Transparency Biopharmaceutical Shareholding Atlas Special Opportunities Oxurion
BRIEF published on 01/06/2025 at 18:05, 1 year 4 months ago Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC Actionnariat Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE published on 01/06/2025 at 18:00, 1 year 4 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV received a transparency notification from Atlas Special Opportunities, LLC revealing a stake above 15% threshold due to purchase of voting securities Transparency Notification Biopharmaceutical Atlas Special Opportunities Ophthalmic Therapies Oxurion NV
PRESS RELEASE published on 01/06/2025 at 18:00, 1 year 4 months ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC Oxurion NV receives transparency notification from Atlas Special Opportunities LLC regarding ownership of 624,817 shares, exceeding the 15% threshold Transparency Notification Share Ownership Atlas Special Opportunities LLC Oxurion NV Ophthalmological Therapies
BRIEF published on 01/03/2025 at 18:05, 1 year 4 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Shares Transparency Biopharmaceutical Atlas Special Opportunities Oxurion
BRIEF published on 01/03/2025 at 18:05, 1 year 4 months ago Oxurion reçoit une notification de transparence de la part d'Atlas Special Opportunities LLC Actions Transparence Biopharmaceutique Oxurion Opportunités Spéciales Atlas
PRESS RELEASE published on 01/03/2025 at 18:00, 1 year 4 months ago Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC Oxurion NV received a transparency notification under Belgian Transparency legislation from Atlas Special Opportunities, LLC, regarding the sale of voting securities Transparency Notification Atlas Special Opportunities LLC Oxurion NV Belgian Legislation Retinal Disease Therapy
PRESS RELEASE published on 01/03/2025 at 18:00, 1 year 4 months ago Oxurion ontvangt transparantiekennisgeving van Atlas Special Opportunities LLC Oxurion NV announces receipt of transparency notification regarding shareholding. Bio-pharmaceutical company developing ophthalmological therapies. Refer to website for more details Transparency Notification Shareholding Belgium Oxurion NV Ophthalmological Therapies
Published on 05/07/2026 at 22:05, 1 hour 20 minutes ago MicroVision and Avular Collaborate to Advance Autonomous Sensing and Drone Integration for Next-Generation Infrastructure Applications
Published on 05/07/2026 at 22:05, 1 hour 20 minutes ago Innodata Reports Record First Quarter 2026 Results
Published on 05/07/2026 at 18:30, 4 hours 55 minutes ago Silver Storm Announces Mobilization of Underground Mine Development Contractors at La Parrilla
Published on 05/07/2026 at 16:35, 6 hours 50 minutes ago Caledonia Mining Corporation Plc New Corporate Video
Published on 05/07/2026 at 23:14, 10 minutes ago EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 1 hour 19 minutes ago Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 2 hours 42 minutes ago RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 4 hours 39 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/07/2026 at 18:35, 4 hours 49 minutes ago Seminole Hard Rock Casino Named Official Miami World Cup 2026™ Host City Supporter
Published on 05/07/2026 at 19:15, 4 hours 10 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 4 hours 10 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 4 hours 19 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 4 hours 19 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 4 hours 25 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL